ReP USP - Resultado da busca

Artigo de periodico
Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin (2009)
Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Clinica Lipidology. Unidade: FCF
Subjects: DOENÇAS CARDIOVASCULARES, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo e HIRATA, Mario Hiroyuki. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, v. 4, n. 4, p. 419-423, 2009Tradução . . Disponível em: https://doi.org/10.2217/clp.09.32. Acesso em: 20 jun. 2024.
APA
Hirata, R. D. C., & Hirata, M. H. (2009). Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, 4( 4), 419-423. doi:10.2217/clp.09.32
NLM
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 jun. 20 ] Available from: https://doi.org/10.2217/clp.09.32
Vancouver
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 jun. 20 ] Available from: https://doi.org/10.2217/clp.09.32
Artigo de periodico
Statin regulation of CYP3A4 and CYP3A5 expression (2009)
Willrich, Maria Alice Vieira; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: FARMACOGENÉTICA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILLRICH, Maria Alice Vieira e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, v. 10, n. 6, p. 1017-1024, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.42. Acesso em: 20 jun. 2024.
APA
Willrich, M. A. V., Hirata, M. H., & Hirata, R. D. C. (2009). Statin regulation of CYP3A4 and CYP3A5 expression. Pharmacogenomics, 10( 6), 1017-1024. doi:10.2217/pgs.09.42
NLM
Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 jun. 20 ] Available from: https://doi.org/10.2217/pgs.09.42
Vancouver
Willrich MAV, Hirata MH, Hirata RDC. Statin regulation of CYP3A4 and CYP3A5 expression [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1017-1024.[citado 2024 jun. 20 ] Available from: https://doi.org/10.2217/pgs.09.42
Artigo de periodico
Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs (2009)
Rodrigues, Alice Cristina ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: LIPOPROTEÍNAS LDL, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, v. 10, n. 6, p. 1007-1016, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.18. Acesso em: 20 jun. 2024.
APA
Rodrigues, A. C., Hirata, M. H., & Hirata, R. D. C. (2009). Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics, 10( 6), 1007-1016. doi:10.2217/pgs.09.18
NLM
Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 jun. 20 ] Available from: https://doi.org/10.2217/pgs.09.18
Vancouver
Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs [Internet]. Pharmacogenomics. 2009 ; 10( 6): 1007-1016.[citado 2024 jun. 20 ] Available from: https://doi.org/10.2217/pgs.09.18
Artigo de periodico
Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays (2009)
Lima Neto, Lidio Gonçalves; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati; Silbiger, Vivian Nogueira; Pastorelli, Carla Prisinzano; Sampaio, Marcelo Ferraz; Armaganijan, Dikran; Rezende, Adriana Augusto de; Doi, Sonia de Quateli; Hirata, Mario Hiroyuki
Source: Genetic Testing and Molecular Biomarkers. Unidade: FCF
Subjects: POLIMORFISMO, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA NETO, Lidio Gonçalves et al. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, v. 13, n. 3, p. 343-347, 2009Tradução . . Disponível em: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147. Acesso em: 20 jun. 2024.
APA
Lima Neto, L. G., Hirata, R. D. C., Luchessi, A. D., Silbiger, V. N., Pastorelli, C. P., Sampaio, M. F., et al. (2009). Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays. Genetic Testing and Molecular Biomarkers, 13( 3), 343-347. Recuperado de http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
NLM
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 jun. 20 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
Vancouver
Lima Neto LG, Hirata RDC, Luchessi AD, Silbiger VN, Pastorelli CP, Sampaio MF, Armaganijan D, Rezende AA de, Doi S de Q, Hirata MH. Detection of the TLR4 1196C>T polymorphism by mismatched-polymerase chain reaction using plasmid DNA as internal control in restriction fragment length polymorphism assays [Internet]. Genetic Testing and Molecular Biomarkers. 2009 ; 13( 3): 343-347.[citado 2024 jun. 20 ] Available from: http://www.liebertonline.com/doi/pdfplus/10.1089/gtmb.2008.0147
Artigo de periodico
ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells (2009)
Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Pharmacogenomics. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, LIPOPROTEÍNAS LDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia e HIRATA, Mario Hiroyuki e HIRATA, Rosario Dominguez Crespo. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, v. 10, n. 6, p. 997-1005, 2009Tradução . . Disponível em: https://doi.org/10.2217/pgs.09.30. Acesso em: 20 jun. 2024.
APA
Genvigir, F. D. V., Hirata, M. H., & Hirata, R. D. C. (2009). ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells. Pharmacogenomics, 10( 6), 997-1005. doi:10.2217/pgs.09.30
NLM
Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jun. 20 ] Available from: https://doi.org/10.2217/pgs.09.30
Vancouver
Genvigir FDV, Hirata MH, Hirata RDC. ABCA1 expression and statins: inhibitory effect in peripheral blood mononuclear cells [Internet]. Pharmacogenomics. 2009 ; 10( 6): 997-1005.[citado 2024 jun. 20 ] Available from: https://doi.org/10.2217/pgs.09.30
Artigo de periodico
Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells (2009)
Rodrigues, Alice Cristina ; Curi, Rui; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: European Journal of Pharmaceutical Sciences. Unidades: ICB, FCF
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, v. 37, n. 3-4, p. 486-491, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2009.04.006. Acesso em: 20 jun. 2024.
APA
Rodrigues, A. C., Curi, R., Hirata, M. H., & Hirata, R. D. C. (2009). Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. European Journal of Pharmaceutical Sciences, 37( 3-4), 486-491. doi:10.1016/j.ejps.2009.04.006
NLM
Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 jun. 20 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006
Vancouver
Rodrigues AC, Curi R, Hirata MH, Hirata RDC. Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells [Internet]. European Journal of Pharmaceutical Sciences. 2009 ; 37( 3-4): 486-491.[citado 2024 jun. 20 ] Available from: https://doi.org/10.1016/j.ejps.2009.04.006

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em